AnaptysBio, Inc. (ANAB)

ANAB’s buy classification is anchored by constructive short-term moving averages and a price that sits above the pivot, while volume metrics show underlying accumulation. Momentum readings are mixed: simple momentum is positive but RSI and MACD are neutral, indicating limited immediate conviction. The ADX flags a pronounced trend backdrop, although the longer-term moving averages remain higher, so the pattern reads as short-term strength within broader resistance. Volatility is elevated versus peers, suggesting wider intraday swings. Technical takeaway: Buy — short-term momentum and positive OBV favor the near-term bullish tilt.